Telehealth SUD Treatment Needs More Research, Oversight

A growing amount of treatment for substance use disorders (SUDs) has moved to telehealth providers due to the COVID-19 pandemic. This trend likely increased patients’ access to treatment, among other benefits, but researchers and plan sponsors say that the efficacy and value of virtual care modalities in SUD settings is still an open question.

0 Comments
© 2022 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

call-center
May 20

Marketplace, MCOs Will Face a Rocky Transition When PHE Ends

READ MORE
exec-pointing-at-graphs
May 20

Startups Oscar Health, Bright Health Exit Markets & Tighten Belts

READ MORE
humana-logo
May 20

Humana Doubles Down on Primary Care Clinic Investments

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today